Key Record Dates
ClinicalTrials.gov Identifier: | NCT05712200 |
---|---|
Brief Title: | Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) (LILAC-TIMI 76) |
First Submitted : | January 12, 2023 |
First Submitted that Met QC Criteria : | January 25, 2023 |
First Posted : | February 3, 2023 |
Last Update Submitted that Met QC Criteria : | May 12, 2024 |
Last Update Posted : | May 14, 2024 |